Sophia Randolph's Insider Trades & SAST Disclosures
Sophia Randolph's most recent trade in Alx Oncology Holdings Inc was a trade of 1,365 Common Stock done at an average price of $2.6 . Disclosure was reported to the exchange on Aug. 14, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Sophia Randolph.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alx Oncology Holdings Inc | Sophia Randolph | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.58 per share. | 14 Aug 2024 | 1,365 | 325,711 | - | 2.6 | 3,522 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 5.82 per share. | 01 Jul 2024 | 3,273 | 327,076 | - | 5.8 | 19,045 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 13 May 2024 | 10,203 | 332,146 | - | 15.8 | 161,380 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 16.67 per share. | 13 May 2024 | 1,797 | 330,349 | - | 16.7 | 29,959 | Common Stock |
| Alx Oncology Holdings Inc | Randolph Sophia | Director, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 95,000 | 95,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 30,000 | 342,349 | - | 0 | Common Stock | |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 29 Dec 2023 | 3,128 | 312,349 | - | 15.0 | 47,045 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 107,000 | 107,000 | - | - | Common Stock | |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2023 | 34,000 | 315,477 | - | - | Common Stock | |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.34 per share. | 30 Jun 2023 | 1,605 | 281,477 | - | 7.3 | 11,781 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2023 | 6,256 | 19,084 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.81 per share. | 09 Jun 2023 | 6,256 | 283,082 | - | 4.8 | 30,091 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.91 per share. | 09 Jun 2023 | 4,027 | 274,280 | - | 1.9 | 7,692 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2023 | 4,027 | 0 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2023 | 2,546 | 92,629 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 09 Jun 2023 | 2,546 | 276,826 | - | 4.1 | 10,388 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 11.07 per share. | 29 Dec 2022 | 1,617 | 270,253 | - | 11.1 | 17,901 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.81 per share. | 16 Dec 2022 | 25,339 | 271,870 | - | 4.8 | 121,881 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2022 | 25,339 | 25,340 | - | - | Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 16 Dec 2022 | 12,731 | 246,531 | - | 4.1 | 51,942 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2022 | 12,731 | 95,175 | - | - | Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.91 per share. | 16 Dec 2022 | 8,404 | 233,800 | - | 1.9 | 16,052 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2022 | 8,404 | 4,027 | - | - | Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 123,000 | 123,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 37,000 | 225,396 | - | 0 | Common Stock | |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 15 Dec 2021 | 12,793 | 177,337 | - | 1.0 | 12,665 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2021 | 12,793 | 0 | - | - | Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.91 per share. | 15 Dec 2021 | 11,059 | 188,396 | - | 1.9 | 21,123 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2021 | 11,059 | 12,431 | - | - | Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2021 | 30,000 | 107,906 | - | - | Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share. | 22 Nov 2021 | 30,000 | 179,428 | - | 4.1 | 122,400 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 36.77 per share. | 22 Nov 2021 | 14,884 | 164,544 | - | 36.8 | 547,314 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 60.79 per share. | 11 Oct 2021 | 4,948 | 151,867 | - | 60.8 | 300,776 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 61.36 per share. | 11 Oct 2021 | 2,439 | 149,428 | - | 61.4 | 149,646 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 77.69 per share. | 10 Sep 2021 | 5,029 | 158,273 | - | 77.7 | 390,682 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 78.31 per share. | 10 Sep 2021 | 1,458 | 156,815 | - | 78.3 | 114,183 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 76.45 per share. | 10 Sep 2021 | 900 | 163,302 | - | 76.5 | 68,806 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 64.76 per share. | 10 Aug 2021 | 5,599 | 164,272 | - | 64.8 | 362,566 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 64.20 per share. | 10 Aug 2021 | 1,718 | 169,871 | - | 64.2 | 110,291 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 65.46 per share. | 10 Aug 2021 | 70 | 164,202 | - | 65.5 | 4,582 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2021 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 54.86 per share. | 12 Jul 2021 | 7,087 | 171,889 | - | 54.9 | 388,770 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 55.86 per share. | 12 Jul 2021 | 300 | 171,589 | - | 55.9 | 16,757 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 62.12 per share. | 10 May 2021 | 4,433 | 187,392 | - | 62.1 | 275,378 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 61.12 per share. | 10 May 2021 | 1,925 | 191,825 | - | 61.1 | 117,654 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 62.79 per share. | 10 May 2021 | 956 | 186,436 | - | 62.8 | 60,026 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 64.56 per share. | 10 May 2021 | 73 | 186,363 | - | 64.6 | 4,713 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 60.29 per share. | 12 Apr 2021 | 2,941 | 194,293 | - | 60.3 | 177,299 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 58.06 per share. | 12 Apr 2021 | 2,903 | 198,234 | - | 58.1 | 168,541 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 59.15 per share. | 12 Apr 2021 | 1,000 | 197,234 | - | 59.1 | 59,148 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 63.51 per share. | 12 Apr 2021 | 284 | 193,750 | - | 63.5 | 18,037 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 61.59 per share. | 12 Apr 2021 | 259 | 194,034 | - | 61.6 | 15,953 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 74.35 per share. | 10 Mar 2021 | 4,844 | 202,383 | - | 74.3 | 360,151 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 73.38 per share. | 10 Mar 2021 | 1,297 | 207,227 | - | 73.4 | 95,177 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 75.20 per share. | 10 Mar 2021 | 1,146 | 201,237 | - | 75.2 | 86,177 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Director, Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 76.69 per share. | 10 Mar 2021 | 100 | 201,137 | - | 76.7 | 7,669 | Common Stock |
| Alx Oncology Holdings Inc | Sophia Randolph | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 89,657 | 89,657 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges